OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The impact of early therapies for COVID-19 on death, hospitalization and persisting symptoms: a retrospective study
Paola Bertuccio, Melania Degli Antoni, Davide Minisci, et al.
Infection (2023) Vol. 51, Iss. 6, pp. 1633-1644
Open Access | Times Cited: 15

Showing 15 citing articles:

Joint analysis of time-varying effect of vaccine and antiviral drug for preventing severe complications and mortality
Jialiang Jiang, Kwok Fai Lam, Eric H. Y. Lau, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 2

COVID-19 therapeutics
Daniele Focosi, Massimo Franchini, Fabrizio Maggi, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 2
Closed Access | Times Cited: 13

Early use of oral antiviral drugs and the risk of post COVID-19 syndrome: A systematic review and network meta-analysis
Juan Jiang, Yantong Li, Qiaoling Jiang, et al.
Journal of Infection (2024) Vol. 89, Iss. 2, pp. 106190-106190
Closed Access | Times Cited: 10

The efficacy of antivirals, corticosteroids, and monoclonal antibodies as acute COVID-19 treatments in reducing the incidence of long COVID: a systematic review and meta-analysis
Gangqiang Sun, Ke Lin, Jingwen Ai, et al.
Clinical Microbiology and Infection (2024) Vol. 30, Iss. 12, pp. 1505-1513
Closed Access | Times Cited: 9

Effectiveness of Antiviral Therapy on Long COVID: A Systematic Review and Meta-Analysis
Yu Jung Choi, Yu Bin Seo, Jun-Won Seo, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 23, pp. 7375-7375
Open Access | Times Cited: 19

How Does Long-COVID Impact Prognosis and the Long-Term Sequelae?
Carolina Baroni, Jorge Potito, María Eugenia Perticone, et al.
Viruses (2023) Vol. 15, Iss. 5, pp. 1173-1173
Open Access | Times Cited: 11

Pharmacologic and Nonpharmacologic Treatment of Long COVID: A Meta-narrative Review
Bala Munipalli, Nancy L. Dawson, J. Calvo Rosales, et al.
SN Comprehensive Clinical Medicine (2025) Vol. 7, Iss. 1
Closed Access

Effectiveness of azvudine against severe outcomes among hospitalized COVID-19 patients in Xinjiang, China: a single-center, retrospective, matched cohort study
Abiden Kapar, Songsong Xie, Zihao Guo, et al.
Expert Review of Anti-infective Therapy (2024) Vol. 22, Iss. 7, pp. 569-577
Closed Access | Times Cited: 1

Azvudine efficacy in reducing mortality in COVID-19 patients
Zhen Zhong, Xiaofeng Liu, Xiaozhong Zhou, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 1

Blood‐derived product therapies for SARS‐CoV‐2 infection and long COVID
Junzheng Wu, Huichuan Yang, Ding Yu, et al.
MedComm (2023) Vol. 4, Iss. 6
Open Access | Times Cited: 3

Emerging small-molecule antiviral agents in long COVID prevention
Xiaomeng He, Xiang Zhang, Wu Zhong
Frontiers in Pharmacology (2024) Vol. 15
Open Access

Pharmacotherapy from Pre-COVID to Post-COVID: Longitudinal Trends and Predictive Indicators for Long COVID Symptoms
Nadia Baalbaki, Sien T. Verbeek, Harm Jan Bogaard, et al.
Biomedicines (2024) Vol. 12, Iss. 12, pp. 2694-2694
Open Access

Page 1

Scroll to top